These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 23196525

  • 21. Overview of the safety of newer antiepileptic drugs.
    Shorvon S, Stefan H.
    Epilepsia; 1997; 38 Suppl 1():S45-51. PubMed ID: 9092960
    [Abstract] [Full Text] [Related]

  • 22. Antiepileptic drugs in development: prospects for the near future.
    Leppik IE.
    Epilepsia; 1994; 35 Suppl 4():S29-40. PubMed ID: 8174517
    [Abstract] [Full Text] [Related]

  • 23. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures.
    Hosford DA, Wang Y.
    Epilepsia; 1997 Apr; 38(4):408-14. PubMed ID: 9118845
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood.
    McDonald DG, Najam Y, Keegan MB, Whooley M, Madden D, McMenamin JB.
    Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564
    [Abstract] [Full Text] [Related]

  • 34. Anticonvulsant drugs in primary headaches prophylaxis.
    Frediani F.
    Neurol Sci; 2004 Oct; 25 Suppl 3():S161-6. PubMed ID: 15549529
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Pharmacokinetic profile of topiramate in comparison with other new antiepileptic drugs.
    Perucca E.
    Epilepsia; 1996 Oct; 37 Suppl 2():S8-S13. PubMed ID: 8641245
    [Abstract] [Full Text] [Related]

  • 40. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?
    Johannessen SI, Tomson T.
    Clin Pharmacokinet; 2006 Oct; 45(11):1061-75. PubMed ID: 17048972
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.